Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Aug 11, 2023
Open Peer Review Period: Aug 10, 2023 - Oct 5, 2023
Date Accepted: Apr 29, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Home-Based Connected Devices Combined With Statistical Process Control for the Early Detection of Respiratory Exacerbations by Patients With Cystic Fibrosis: Pilot Interventional Study With a Pre-Post Design

Le Roux E, Ursino M, Milovanovic I, Picq P, Haignere J, Rault G, Pougheon Bertrand D, Alberti C

Home-Based Connected Devices Combined With Statistical Process Control for the Early Detection of Respiratory Exacerbations by Patients With Cystic Fibrosis: Pilot Interventional Study With a Pre-Post Design

JMIR Form Res 2024;8:e51753

DOI: 10.2196/51753

PMID: 39467550

PMCID: 11555459

Homebased connected devices combined with statistical process control for the early detection of respiratory exacerbations in patients with cystic fibrosis: a pilot study

  • Enora Le Roux; 
  • Moreno Ursino; 
  • Ivana Milovanovic; 
  • Paul Picq; 
  • Jeremie Haignere; 
  • Gilles Rault; 
  • Dominique Pougheon Bertrand; 
  • Corinne Alberti

ABSTRACT

Background:

Currently, patients with cystic fibrosis do not routinely monitor their respiratory function at home.

Objective:

This study aims to assess the clinical validity of the use of different connected health devices at home measuring 5 physiological parameters to help preventing exacerbations on a personalised basis in a perspective of patient empowerment

Methods:

A multicenter interventional pilot study was led including 36 patients. The use of statistical process control (CUSUM) was applied to connected health devices measures with the objective to send patients alerts in relevant time on their individual risk of exacerbations. Associated patient education was delivered. Quantitative and qualitative data were collected

Results:

Half of the patients completed the protocol to the end. During the 12 months of interventions patients realised 6162 measures with connected health devices, 387 alerts were send and 33 exacerbations were reported. Alerts precision for exacerbation detection was weak for all parameters which may be partly related to the low compliance of patients with measurement. However a diminution in the median numbers of exacerbations was observed in patients when comparing their numbers 12 months before the inclusion and the 12 months of the intervention.

Conclusions:

The use of connected health devices associated with statistical process control showed that these methods were very demanding for the patients and that this type of intervention was not acceptable for every patient. Avenues for improving the use of connected tools for early identification and better management of exacerbations are proposed Clinical Trial: NCT03304028


 Citation

Please cite as:

Le Roux E, Ursino M, Milovanovic I, Picq P, Haignere J, Rault G, Pougheon Bertrand D, Alberti C

Home-Based Connected Devices Combined With Statistical Process Control for the Early Detection of Respiratory Exacerbations by Patients With Cystic Fibrosis: Pilot Interventional Study With a Pre-Post Design

JMIR Form Res 2024;8:e51753

DOI: 10.2196/51753

PMID: 39467550

PMCID: 11555459

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.